Browse Items (21 total)

Tags: 1.3.1, 15.1, developing countries--[pri], genetic engineering--[pri], genetic enhancement--[pri], genetics--[pri]

Tags: 19.1, 19.5, 21.1, 9.3.1, commerce--[pri], developing countries--[pri], disadvantaged persons--[pri], international aspects--[pri], organ donation--[pri], organ transplantation--[pri], vulnerable populations--[pri]

Tags: 1.3.12, 1.3.9, 15.1, 18.2, 21.1, attitudes--[pri], benefit sharing--[pri], cooperative behavior--[pri], developed countries--[pri], developing countries--[pri], international aspects--[pri], policy making--[pri], researchers--[pri], specimen collection--[pri]

Tags: 18.3, 21.1, 8.3.1, developing countries--[pri], informed consent--[pri], Pakistan--[pri]

Tags: 20.4.1, developing countries--[pri], Egypt--[pri], palliative care--[pri]

Tags: 20.4.1, developing countries--[pri], Pakistan--[pri], palliative care--[pri]

Tags: 21.1, 9.1, 9.3.1, developing countries--[pri], international aspects--[pri], medical tourism--[pri], sex factors--[pri], socioeconomic factors--[pri], Yemen--[pri]

Tags: 18.2, 18.3, 21.1, community consent--[pri], controlled clinical trials--[pri], developing countries--[pri], health services research--[pri], public health--[pri], random selection--[pri]

Tags: 21.6, developed countries--[pri], developing countries--[pri], health personnel--[pri], immigrants--[pri], international aspects--[pri], socioeconomic factors--[pri]

Tags: 14.1, 14.4, 21.1, developing countries--[pri], reproductive health services--[pri], reproductive rights--[pri], reproductive technologies--[pri]

Tags: 2.1, 21.1, bioethics--[pri], democracy--[pri], developing countries--[pri], freedom--[pri], political systems--[pri]

Tags: 1.3.9, 18.2, 18.4, 18.5.9, behavioral research--[pri], biomedical research--[pri], developing countries--[pri], ethical review--[pri], human experimentation--[pri], Mediterranean Region--[pri], Middle East--[pri], qualitative research--[pri], research ethics--[pri]

Tags: 15.1, 15.10, 21.7, developing countries--[pri], genetic epidemiology--[pri], genomics--[pri], international aspects--[pri], research priorities--[pri]

Tags: 18.1, 9.3.1, developing countries--[pri], human experimentation--[pri], incentives--[pri], remuneration--[pri], research subjects--[pri]

Tags: 1.2, 1.3.2, 16.1, 16.3, 21.1, 9.1, 9.3.1, 9.8, developed countries--[pri], developing countries--[pri], environment--[pri], environmental health--[pri], health hazards--[pri], industry--[pri], international aspects--[pri], Islamic ethics--[pri], Muslim world--[pri], proprietary health facilities--[pri]

Tags: 18.2, 18.5.9, 18.6, 9.7, clinical trials--[pri], developing countries--[pri], drug industry--[pri], Pakistan--[pri]

Tags: 18.2, 18.5.9, 18.6, 18.7, 21.7, 8.1, 9.7, developing countries--[pri], human experimentation--[pri], industry--[pri], Pakistan--[pri]

Tags: 18.2, 18.5.9, 18.6, 21.1, developing countries--[pri], guidelines--[pri], human experimentation--[pri]

Tags: 19.3, 19.5, 19.6, 21.1, 9.3.1, developing countries--[pri], kidneys--[pri], organ donation--[pri], organ transplantation--[pri]

Tags: 21.1, developing countries--[pri], international aspects--[pri], vulnerable populations--[pri]